A. Lorenz

Inactivating calcium‐sensing receptor mutations in patients with primary hyperparathyroidism

F. Raue, G. Leidig-Bruckner, K. Frank‐Raue, 2011, Clinical endocrinology.

Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.

M. Kreissl, K. Schmid, H. Dralle, 2013, Thyroid : official journal of the American Thyroid Association.

Diagnostic Challenge of Rapid Enlargement of the Thyroid: Autoimmuneb Thyroiditis - Thyroid Lymphoma - Malignant Thyroid Disease

T. Musholt, F. Raue, G. Leidig-Bruckner, 2013 .

Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels—an observational study during clinical practice conditions

T. Bruckner, F. Raue, G. Leidig-Bruckner, 2010, Osteoporosis International.

[Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].

M. Büchler, F. Raue, G. Leidig-Bruckner, 2011, Deutsche medizinische Wochenschrift.

Severe form of thyroid hormone resistance in a patient with homozygous/hemizygous mutation of T3 receptor gene.

F. Raue, K. Frank‐Raue, D. Knorr, 2004, European journal of endocrinology.

New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.

J. Döhring, H. Dralle, F. Raue, 2009, Experimental and clinical endocrinology & diabetes.